<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04591795</url>
  </required_header>
  <id_info>
    <org_study_id>MTU-EC-TM-2-116_2/59</org_study_id>
    <nct_id>NCT04591795</nct_id>
  </id_info>
  <brief_title>Sahastara Remedy Extract Capsule in Primary Osteoarthritis of Clinical Trial Phase II</brief_title>
  <official_title>Efficacy and Safety of Sahastara Remedy Extract Capsules in Treating Primary Osteoarthritis of the Knee Compared With Diclofenac (Clinical Trial Phase II)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mr NARIN KAKATUM</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Thammasat University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To study efficacy and safety of Sahastara 95% ethanolic extract capsules compared to&#xD;
      treatment Primary osteoarthritis for primary osteoarthritis, it was compared with diclofenac&#xD;
      (Phase II).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sample size 66 volunteers&#xD;
&#xD;
      The patients were divided randomly into 2 treatment groups. The patients in group 1 received&#xD;
      the SHT extract 300 mg/day (1 capsule of 100 mg SHT extract three times daily before meals).&#xD;
      The patients in group 2 received diclofenac sodium 75 mg/day (1 capsule of 25 mg diclofenac&#xD;
      three times daily after meals). In addition, the patients in both groups received 20 mg of&#xD;
      omeprazole, 1 capsule before breakfast for protects of Gastrointestinal adverse effects.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">October 13, 2020</completion_date>
  <primary_completion_date type="Actual">October 13, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score 1</measure>
    <time_frame>28 day</time_frame>
    <description>Pain score from Visual analog scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score 2</measure>
    <time_frame>28 day</time_frame>
    <description>Pain score from Modified WOMAC score (from Modified Thai WOMAC index)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>100 mg SHT extract</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: Sahastara remedy alcoholic extract comparison with diclofenac</description>
  </arm_group>
  <arm_group>
    <arm_group_label>25 mg dicolfenac</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug: diclofenac comparison with diclofenac</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sahastara remedy extract</intervention_name>
    <description>The concentration of SHT extract is 100 mg per capsule</description>
    <arm_group_label>25 mg dicolfenac</arm_group_label>
    <other_name>SHT extract</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac</intervention_name>
    <description>Diclofenac sodium, 25 mg enteric-coated tablets</description>
    <arm_group_label>100 mg SHT extract</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No pregnancy&#xD;
&#xD;
          -  No Serious Medical Condition evaluated by Physical Examination and Laboratory results&#xD;
             in 1 month before study&#xD;
&#xD;
          -  No Supplementary food and/or Vitamin during the study Able to follow suggestion during&#xD;
             the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Uncontrolled Hypertension (BP&gt;140/90 mm.Hg.) BMI &gt; 30&#xD;
&#xD;
          -  Have serious medical condition including Severe peptic ulcer, congestive heart&#xD;
             disease, Liver and Renal dysfunction.&#xD;
&#xD;
          -  On during use medicine including Rifampicin, Phenytoin, Propranolol, Theophylline&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Associate Professor Arunporn Itharat, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>faculty of Medicine, Thammasat University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mr.NARIN KAKATUM</last_name>
    <phone>0667867161</phone>
    <email>narin.ka@ssru.ac.th</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Associate Professor Arunporn Itharat</last_name>
    <phone>0667867161</phone>
    <email>iarunporn@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mr. NARIN KAKATUM</name>
      <address>
        <city>Bangkok</city>
        <state>BKK</state>
        <zip>11130</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>October 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <last_update_submitted>October 12, 2020</last_update_submitted>
  <last_update_submitted_qc>October 12, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Thammasat University</investigator_affiliation>
    <investigator_full_name>Mr NARIN KAKATUM</investigator_full_name>
    <investigator_title>Faculty of Medicine</investigator_title>
  </responsible_party>
  <keyword>Sahastara</keyword>
  <keyword>Osteoarthritis</keyword>
  <keyword>Herbal Medicine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>October 17, 2020</submitted>
    <returned>November 9, 2020</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

